OMRON Corp (OMRNY) fair value: what the stock is really worth
As of Oct 22, 2026: fair value (intrinsic value) of OMRON Corp stock $20.44, price $34.75, upside -41.2%, quality 50 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 22, 2026.
How to read this chart
60‑month range $22.95 – $95.79 · fair‑value band $14.31 – $26.58 · the $34.75 price screens above the $20.44 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 22, 2026.
Follow OMRON Corp ADR in your weekly email
Every Wednesday you see whether OMRON Corp ADR is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
OMRON Corporation engages in industrial automation, device and module solutions, data solutions, social systems, and healthcare businesses in Japan and internationally.
Show moreShow less
It provides sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products.
The company also offers environmental mobility, digital devices, food and commodities, logistics and warehouse automation, medical, robotic, panel, vision, software, and traceability solutions.
In addition, it provides power storage systems; station systems, such as automatic ticket gates and ticket vending machines, traffic control systems, and payment systems; and data and power protection systems comprising UPS, as well as software development and maintenance services.
Further, the company offers cardiovascular, respiratory care, pain management, remote patient monitoring, and other solutions. Additionally, it provides relays, switches, connectors, and sensors. OMRON Corporation was founded in 1933 and is headquartered in Kyoto, Japan.
Stock analysis
OMRON Corp (OMRNY) currently trades at $34.75, while our model-based Fair Value estimate is $20.44, 41.2% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $27.41 per share, and 4 of the 24 models we run sit above the $34.75 price.
Bear case: the Growth DCF group reads lowest at $6.26, and 20 of the 24 models stay below the price. Data coverage for this calculation is high.
Scenario range: $14.31 (bear) to $26.58 (bull), the price of $34.75 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (below-average quality), in the Technology sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
OMRON Corp ADR reported revenue of ¥814B in FY2026 versus ¥763B in FY2022, a compound +1.6%/yr. Reported net income was ¥30.2B in FY2026, compounding −16.3%/yr from FY2022.
Key figures
Market cap $6.8B Mid · P/E ratio 25.6 · P/S ratio 0.95 · EPS (TTM) $1.36 · Dividend yield 1.9% · Net margin 3.7% · Return on equity 5.1% · Return on assets (EBIT) 6.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (low confidence).
What moves the price
The share trades about 22% below its 52-week high and 51% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −44% fair-value upside, at −41%, OMRNY screens cheaper than that median.
Fair Value models
Bear$14.31Fair Value $20.44Bull$26.58
Price $34.75 · Upside -41.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then ($0.3935 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+1.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.4%
Start year 2021 (pandemic). Over 10 years: −0.2% a year
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.4%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +3.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.9%
Dividend (yield on the price)1.9%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−6.5% vs −3.5%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 8%
Pace: the 5-year rate starts in 2021 (pandemic)
⚠ Rate on operating basis: 2026 sits 86% above its own trend.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+48.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+5.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about +45.6% a year for the price and +3.4% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (50 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Negative
Recent news coverage is more negative than average.
AI conclusion: Narrowed operations in industrial automation, healthcare and data solutions form the main strength, while persistently low ROE and net margins signal a weak moat in the competitive sector.
Main risk: The completed divestiture of the historical electronic components operations risks leaving the remaining segments unable to deliver steadier profitability and returns.
OMRON just completed the spin-off of its Device and Module Solutions business to Carlyle, now operating independently as Aratas. This move narrows the company to industrial automation, healthcare and data solutions but leaves behind a core electronic components operation that shaped much of its history. Will the streamlined portfolio generate steadier returns than the divested segment delivered?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electronic Components · 645 stocks
Beats the industry median on 8/15 measures
A mixed picture versus its industry peers.
Valuation
Quality Score50 · Below median
Fair Value upside−41.2% · Below median
Profitability
Return on equity (12 months)5.1% · Below median
Return on assets2.0% · Below median
Net margin (12 months)4.3% · Below median
Operating margin (12 months)9.0% · Above median
Growth and dividend
Revenue growth (quarter YoY)10.8% · Below median
Dividend yield (12 months)1.9% · Above median
Balance sheet
Debt / equity0.09× · Below median
Valuation Multiplesvs Electronic Components median · lower = cheaper
P/E (12 months)25.6× · Cheaper than median
P/B1.28× · Cheaper than median
P/S (12 months)1.32× · Cheaper than median
Price / free cash flow129.4× · Priciest 25%
EV/EBITDA9.2× · Cheapest 25%
PEG0.89× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)54· sector 63
PAST (return on equity)21· sector 28
HEALTH (low debt)96· sector 95
DIVIDEND (yield)38· sector 25
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
As of Oct 22, 2026, our model estimates a fair value of $20.44 versus a price of $34.75, about −41% upside (overvalued).
What is the fair value of OMRNY?
Our model-based fair value for OMRON Corp ADR is $20.44 (as of Oct 22, 2026), built from audited fundamentals. The current price: $34.75.
What is the quality score of OMRNY?
OMRON Corp ADR has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for OMRON Corp (OMRNY)?
Our model-based price target is the fair value of $20.44 (as of Oct 22, 2026) from 24 valuation models. Cautious scenario $14.31, optimistic scenario $26.58. It is a calculation from audited fundamentals, not an analyst target.
What is the OMRON Corp ADR stock forecast for 2026?
Our models put fair value at $20.44, about −41% upside versus a price of $34.75 (overvalued). Cautious scenario $14.31, optimistic scenario $26.58. The calculation is refreshed regularly with new filings.
What is the revenue of OMRON Corp (OMRNY)?
OMRON Corp ADR reported trailing-twelve-month revenue of about ¥811B (latest available figure, as of Oct 22, 2026).
Does OMRON Corp ADR pay a dividend?
OMRON Corp ADR currently shows a dividend yield of 1.91% relative to its recent price (as of Oct 22, 2026).
What growth is priced into OMRON Corp (OMRNY)?
For today's price to be fair in a discounted-cash-flow model, OMRON Corp ADR would have to grow free cash flow by +48.7 % per year for five years (discount rate 10.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.4 % per year. As of Oct 22, 2026.
What discount rate (WACC) does the fair value of OMRNY use?
Our models discount OMRON Corp ADR at 10.2 %: a base by market capitalisation (mid), damped by beta 1.18, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For OMRON Corp ADR that is +48.7 % per year a year over ten years, using the same discount rate (10.2 %) and the same formula as our fair value.
How much growth has OMRON Corp (OMRNY) delivered so far?
Over the past 5 years revenue at OMRON Corp ADR grew +4.4 % a year. The price currently implies +48.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of OMRON Corp (OMRNY) growing?
The median revenue growth in the sector is +10.8 % a year. That is the yardstick for the growth priced into OMRON Corp ADR (+48.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of OMRON Corp (OMRNY)?
The free-cash-flow yield on the price is 0.77 %: that much free cash flow OMRON Corp ADR produces per unit of market value. When it exceeds the discount rate of our models (10.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of OMRON Corp (OMRNY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For OMRON Corp ADR it is $20.44 per share (as of Oct 22, 2026), against a price of $34.75. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is OMRON Corp ADR stock overvalued or undervalued in 2026?
As of Oct 22, 2026, OMRNY trades above its calculated fair value: price $34.75, fair value $20.44, a gap of about −41% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of OMRNY?
No. The price is what the market pays today ($34.75); the fair value is what the company's own numbers justify ($20.44). For OMRON Corp ADR the two are $14.31 per share apart. That gap is exactly why we show both numbers side by side.
How much is OMRON Corp ADR worth?
The market values OMRON Corp ADR at about $6.8B (market capitalisation, as of Oct 22, 2026). Per share that is $34.75; our models calculate a fair value of $20.44 per share.
What do the bullish and bearish scenarios say about OMRNY?
Our models span a range for OMRON Corp ADR: cautious scenario $14.31, base $20.44, optimistic $26.58 per share (as of Oct 22, 2026, price $34.75). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of OMRNY?
OMRON Corp ADR trades at a price-to-earnings ratio of 25.6 (as of Oct 22, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $20.44 is built from several models across several years. Other multiples: PEG 0.9, P/B 1.3, P/S 1.3, EV/EBITDA 9.2.
What is the PEG ratio of OMRNY?
The PEG ratio of OMRON Corp ADR is 0.89 (P/E divided by earnings growth, as of Oct 22, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of OMRON Corp (OMRNY)?
Balance-sheet figures for OMRON Corp ADR (as of Oct 22, 2026): return on equity 5.1%, debt of 0.09 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is OMRNY from its 52-week high?
OMRON Corp ADR trades at $34.75, about 22% below its 52-week high of $44.44 and 51% above the low of $22.95 (as of Oct 22, 2026). Distance from the high says nothing about value: that is what the fair value of $20.44 is for.
Which stocks are comparable to OMRON Corp ADR?
From the same area (Technology) we also value Amphenol Corporation, Delta Electronics, Inc, Corning Incorporated, Samsung Electro-Mechanics Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is OMRON Corp ADR stock attractive at the current price?
The data as of Oct 22, 2026: price $34.75, calculated fair value $20.44 (−41%), Quality Score 50/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of OMRNY calculated?
We run OMRON Corp ADR through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $20.44, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. OMRON Corp ADR itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of OMRON Corp (OMRNY)?
The closing price on Oct 22, 2026 was $34.75. Our model-based fair value is $20.44, about −41% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with OMRON Corp ADR right now?
The price sits above even our optimistic bull case ($26.58). The favourable scenario is already priced in. Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($14.31 to $26.58) leaves room in how you read the outcome.
Where does the earnings growth of OMRON Corp (OMRNY) come from?
Earnings per share at OMRON Corp ADR grew −10.0 % a year from 2015 to 2026. Broken into its drivers: revenue per share +0.9 %, EBIT margin −3.6 %, tax rate −1.8 %, residual (interest, one-offs) −5.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of OMRON Corp ADR
How large is the market capitalisation of OMRON Corp (OMRNY)?
The market capitalisation of OMRON Corp ADR is $6.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of OMRON Corp (OMRNY)?
The price-to-sales ratio of OMRON Corp ADR is 0.95 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of OMRON Corp (OMRNY)?
Earnings per share at OMRON Corp ADR are $1.36 (price ÷ EPS = P/E 25.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of OMRON Corp (OMRNY)?
The dividend yield of OMRON Corp ADR is 1.9% (payout 48.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of OMRON Corp (OMRNY)?
The net margin of OMRON Corp ADR is 3.7% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of OMRON Corp (OMRNY)?
The return on equity (ROE) of OMRON Corp ADR is 5.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of OMRON Corp (OMRNY)?
On an EBIT basis the return on assets of OMRON Corp ADR is 6.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of OMRON Corp (OMRNY)?
The operating margin of OMRON Corp ADR is 9.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at OMRON Corp (OMRNY)?
Revenue at OMRON Corp ADR is growing +10.8% versus a year earlier (3y avg −2.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at OMRON Corp (OMRNY)?
Earnings per share at OMRON Corp ADR are growing +56.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does OMRON Corp (OMRNY) carry?
The net debt of OMRON Corp ADR is ¥75.0B (fiscal year 2026, ≈ 9.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch OMRON Corp ADR in the live analysis
One click puts OMRON Corp ADR on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Broad data
Oct 22, 2026